Indefinite Delivery Contract SPE2DX15D9646

The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded an indefinite delivery contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, valued at up to $499,999,999 to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities worldwide. The contract, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.

The contract has an ultimate completion date of December 31, 2025. Task orders issued to date under this IDC include delivery of medications such as Xolair, Trikafta, Keytruda, Botox, Nucala, Reese's Pinworm, Intralipid, Reglan, Hextend, Famotidine, Dexamethasone, Omeprazole, Levothyroxine, Heparin, Hydroxyzine, Neomycin-Bacitracin-Polymyxin eye ointment, Cleocin, Solu-Cortef, Flumazenil, Cyclogyl, and Acyclovir. The orders, which are predominantly firm fixed-price, cover a wide range of medical needs and are fulfilled from DMS Pharmaceutical Group's facilities in Park Ridge, Illinois.